Price loading...

Springer Vaccines for Pandemic Influenza: 333 (Current Topics in Microbiology and Immunology, 333)

Price data last checked 106 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

Recent years have seen unprecedented outbreaks of avian influenza A viruses. In particular, highly pathogenic H5N1 viruses have not only resulted in widespread outbreaks in domestic poultry, but have been transmitted to humans, resulting in numerous fatalities. The rapid expansion in their geographic distribution and the possibility that these viruses could acquire the ability to spread from person to person raises the risk that such a virus could cause a global pandemic with high morbidity and mortality. An effective influenza vaccine represents the best approach to prevent and control such an emerging pandemic. However, current influenza vaccines are directed at existing seasonal influenza viruses, which have little or no antigenic relationship to the highly pathogenic H5N1 strains. Concerns about pandemic preparedness have greatly stimulated research activities to develop eff- tive vaccines for pandemic influenza viruses, and to overcome the limitations inh- ent in current approaches to vaccine production and distribution. These limitations include the use of embryonated chicken eggs as the substrate for vaccine prod- tion, which is time-consuming and could involve potential biohazards in growth of new virus strains. Other limitations include the requirement that the current inac- vated influenza vaccines be administered using needles and syringes, requiring trained personnel, which could be a bottleneck when attempting to vaccinate large populations in mass campaigns. In addition, the current inactivated vaccines that are delivered by injection elicit limited protective immunity in the upper respiratory tract where the infection process is initiated.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
28 July 2009
Listed Since
10 November 2008

Barcode

No barcode data available

Similar Products You Might Like

Vaccines for Pandemic Influenza: 333 (Current Topics in Microbiology and Immunology, 333)
99% match

Vaccines for Pandemic Influenza: 333 (Current Topics in Microbiology and Immunology, 333)

Springer

£203.06 10 Mar 2026
Influenza Virology: Current Topics
94% match

Influenza Virology: Current Topics

Caister Academic Press Limited

£214.00 12 Jan 2026
Mucosal Vaccines: Modern Concepts, Strategies, and Challenges: 354 (Current Topics in Microbiology and Immunology, 354)
93% match

Mucosal Vaccines: Modern Concepts, Strategies, and Challenges: 354 (Current Topics in Microbiology and Immunology, 354)

Springer

£107.43 09 Mar 2026
Influenza: Molecular Virology
93% match

Influenza: Molecular Virology

Caister Academic Press Limited

£199.00 13 Jan 2026
Mucosal Vaccines: Modern Concepts, Strategies, and Challenges: 354 (Current Topics in Microbiology and Immunology, 354)
92% match

Mucosal Vaccines: Modern Concepts, Strategies, and Challenges: 354 (Current Topics in Microbiology and Immunology, 354)

Springer

£101.00 09 Mar 2026
Plant-produced Microbial Vaccines: 332 (Current Topics in Microbiology and Immunology, 332)
92% match

Plant-produced Microbial Vaccines: 332 (Current Topics in Microbiology and Immunology, 332)

Springer

£107.27 17 Feb 2026
Influenza
92% match

Influenza

Springer

£75.60 07 Mar 2026
Vaccination Strategies Against Highly Variable Pathogens: 428 (Current Topics in Microbiology and Immunology, 428)
92% match

Vaccination Strategies Against Highly Variable Pathogens: 428 (Current Topics in Microbiology and Immunology, 428)

Springer

£95.11 07 Mar 2026
Vaccination Strategies Against Highly Variable Pathogens: 428 (Current Topics in Microbiology and Immunology, 428)
92% match

Vaccination Strategies Against Highly Variable Pathogens: 428 (Current Topics in Microbiology and Immunology, 428)

Springer

£95.72 07 Feb 2026
Influenza Pathogenesis and Control - Volume II: 386 (Current Topics in Microbiology and Immunology, 386)
92% match

Influenza Pathogenesis and Control - Volume II: 386 (Current Topics in Microbiology and Immunology, 386)

Springer

£114.71 03 Mar 2026
Nanoparticles for Rational Vaccine Design: 433 (Current Topics in Microbiology and Immunology, 433)
92% match

Nanoparticles for Rational Vaccine Design: 433 (Current Topics in Microbiology and Immunology, 433)

Springer

£76.04 24 Feb 2026
Avian Virology: Current Research and Future Trends
92% match

Avian Virology: Current Research and Future Trends

Caister Academic Press Limited

£199.00 06 Jan 2026
Challenges and Opportunities for Respiratory Syncytial Virus Vaccines: 372 (Current Topics in Microbiology and Immunology, 372)
92% match

Challenges and Opportunities for Respiratory Syncytial Virus Vaccines: 372 (Current Topics in Microbiology and Immunology, 372)

Springer

£112.76 07 Jan 2026
Human Challenge Studies for Vaccine Development: 445 (Current Topics in Microbiology and Immunology, 445)
92% match

Human Challenge Studies for Vaccine Development: 445 (Current Topics in Microbiology and Immunology, 445)

£133.85 12 Jan 2026
Pulmonary Infection: 857 (Advances in Experimental Medicine and Biology, 857)
92% match

Pulmonary Infection: 857 (Advances in Experimental Medicine and Biology, 857)

Springer

£72.63 06 Mar 2026
Modern Infectious Disease Epidemiology: Concepts, Methods, Mathematical Models, and Public Health (Statistics for Biology and Health)
92% match

Modern Infectious Disease Epidemiology: Concepts, Methods, Mathematical Models, and Public Health (Statistics for Biology and Health)

Springer

£114.99 02 Mar 2026
Veterinary Vaccines: Current Innovations and Future Trends
92% match

Veterinary Vaccines: Current Innovations and Future Trends

Caister Academic Press Limited

£198.98 12 Jan 2026
Plotkin's Vaccines (Vaccines (Plotkin))
92% match

Plotkin's Vaccines (Vaccines (Plotkin))

Elsevier

£204.71 16 Mar 2026
Convalescent Plasma and Other Antibody Therapies for Infectious Diseases: Lessons learned from COVID-19 and Future Prospects: 443 (Current Topics in Microbiology and Immunology, 443)
92% match

Convalescent Plasma and Other Antibody Therapies for Infectious Diseases: Lessons learned from COVID-19 and Future Prospects: 443 (Current Topics in Microbiology and Immunology, 443)

£147.93 06 Feb 2026
Springer Intradermal Immunization: 351 Microbiology Book
92% match

Springer Intradermal Immunization: 351 Microbiology Book

Springer

£107.43 07 Mar 2026
Springer Novel Strategies in Vaccine Design and Production 397
92% match

Springer Novel Strategies in Vaccine Design and Production 397

Springer

£109.03 10 Mar 2026
How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)
92% match

How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)

Springer

£119.08 18 Apr 2026
How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)
92% match

How to Overcome the Antibiotic Crisis: Facts, Challenges, Technologies and Future Perspectives: 398 (Current Topics in Microbiology and Immunology, 398)

Springer

£126.23 08 Feb 2026
Antibodies in Viral Infection: 260 (Current Topics in Microbiology and Immunology, 260)
91% match

Antibodies in Viral Infection: 260 (Current Topics in Microbiology and Immunology, 260)

Springer

£144.44 10 Mar 2026